Track the ST海王 stock price and the full insider trade history of the company, a listed issuer based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, ST海王 has recorded 8 insider filings. Market capitalisation: €4.3bn. The latest transaction was reported on 24 August 2026 (Purchase). Among the most active insiders: 金戈. Every trade is openly available.
8
Insider Decl.
n/a
Thresholds
€173,297
7 ops.
Buy Volume
€230,235
1 ops.
Sell Volume
15Σ signal
Buys €173,297€230,235 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,468 of 28,985 companies
16.1
score / 100
Value
18
Quality
15
FCF yld-0.5%
Earn yld-13%
EV/EBITDA46.8x
ROE-23%
Gross mgn9.2%
Net mgn-2.1%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
ST海王 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and distribution of pharmaceutical products.